APAC IPOs & Placements, Aequitas Research

Hong Jie Seow

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

Aequitas: Sunway Healthcare IPO - Premium Valuation Caps Near Term Upside

Aequitas: Sunway Healthcare IPO Trading - Decent Retail Demand, Though Upside Is Unclear

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Sunway Healthcare Holdings / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sunway-healthcare" target="_blank" data-smartkarma-citation="entities:45839:1" rel="noopener">Sunway Healthcare (2268774D MK)</a> is looking to raise US$800m in its upcoming Malaysia IPO.</li>
<li>Sunway Healthcare Holdings, one of the largest private hospital groups and the only private hospital group (among major private hospitals) in Malaysia that covers the full lifecycle of care.</li>
<li>In this note, we look at the company’s past performance.</li>
</ul>



Sunway Healthcare (2268774D MK) is looking to raise US$800m in its upcoming Malaysia IPO.
Sunway Healthcare Holdings, one of the largest private hospital groups and the only private hospital group (among major private hospitals) in Malaysia that covers the full lifecycle of care.
In this note, we look at the company’s past performance.


Aequitas: Sunway Healthcare, IPO 전 분석 - 강력한 매출 성장세 및 대체로 안정적인 마진